Laura Sánchez‐Íñigo
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Diet, Metabolism, and Disease 4
-
- Cardiovascular Disease and Adiposity 1
- Lipid metabolism and disorders 1
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 5
- Adipokines, Inflammation, and Metabolic Diseases 1
- Acute Ischemic Stroke Management 1
-
- Obesity, Physical Activity, Diet 1
Laura Sánchez‐Íñigo
9 papers receiving 844 citations
Hit Papers
Peers
Comparison fields: 5 of 74
- Endocrinology, Diabetes and Metabolism 537
- Cardiology and Cardiovascular Medicine 354
- Epidemiology 345
- Nephrology 37
- Physiology 107
Countries citing papers authored by Laura Sánchez‐Íñigo
This map shows the geographic impact of Laura Sánchez‐Íñigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Sánchez‐Íñigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Sánchez‐Íñigo more than expected).
Fields of papers citing papers by Laura Sánchez‐Íñigo
This network shows the impact of papers produced by Laura Sánchez‐Íñigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Sánchez‐Íñigo. The network helps show where Laura Sánchez‐Íñigo may publish in the future.
Co-authorship network
The 10 scholars most cited alongside Laura Sánchez‐Íñigo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 4 | |
| 3 | 2022 | 2 | |
| 4 | 2016 | 32 | |
| 5 | 2016 | 99 | |
| 6 | 2016 | 271 | |
| 7 | 2016 | 20 | |
| 8 | 2016 | 41 | |
| 9 | The TyG index may predict the development of cardiovascular eventsbreakdown → | 2015 | 386 |
About Laura Sánchez‐Íñigo
Laura Sánchez‐Íñigo is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Epidemiology, having authored 9 papers that have together received 857 indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Diet, Metabolism, and Disease (4 papers), Obesity, Physical Activity, Diet (1 paper), Cardiovascular Disease and Adiposity (1 paper), Adipokines, Inflammation, and Metabolic Diseases (1 paper), Lipid metabolism and disorders (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (537 citations), Cardiology and Cardiovascular Medicine (354 citations) and Epidemiology (345 citations). Laura Sánchez‐Íñigo has collaborated with scholars based in Spain, Italy and Israel. Frequent co-authors include Alejandro Fernández‐Montero, David Navarro‐González, Juan Pastrana Delgado, J. Alfredo Martínéz, JA Martínez, Diego Martínez‐Urbistondo, Elisabetta Bugianesi, Ana E. Huerta, Manuel F. Landecho and Delia D’Avola. Their work appears in journals such as Medicine, Preventive Medicine and Obesity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.